(Q41428215)

30 September 2017

Rapid prediction of individual dosage requirements for lignocaine (English)

1 reference

30 September 2017

S Vozeh

1

1 reference

30 September 2017

M Berger

2

1 reference

30 September 2017

M Wenk

3

1 reference

30 September 2017

R Ritz

4

1 reference

30 September 2017

F Follath

5

1 reference

30 September 2017

1 July 1984

1 reference

Clinical Pharmacokinetics

30 September 2017

1 reference

30 September 2017

9

1 reference

30 September 2017

354-363

1 reference

30 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198409040-00005

30 September 2017

0 references

cites work

Experience with NONMEM: analysis of serum concentration data in patients treated with mexiletine and lidocaine

1 reference

12 December 2020

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

1 reference

12 December 2020

Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered aminophylline

1 reference

12 December 2020

Effect of Lidocaine on Ventricular Arrhythmias in Patients with Coronary Heart Disease

1 reference

12 December 2020

Improved computer-assisted digoxin therapy. A method using feedback of measured serum digoxin concentrations

1 reference

12 December 2020

Lignocaine kinetics in cardiac patients and aged subjects

1 reference

12 December 2020

Forecasting individual pharmacokinetics

1 reference

12 December 2020

Predicting individual phenytoin dosage

1 reference

12 December 2020

Lidocaine kinetics predicted by indocyanine green clearance

1 reference

12 December 2020

Influence of long-term infusions on lidocaine kinetics.

1 reference

12 December 2020

[Slower lidocaine elimination and dose adjustment in patients with heart failure]

1 reference

12 December 2020

Variability of early lidocaine levels in patients.

1 reference

12 December 2020

Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention.

1 reference

12 December 2020

Control of lidocaine therapy: new perspectives.

1 reference

12 December 2020

On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction

1 reference

12 December 2020

Fluorescence polarization immunoassay. iii. an automated system for therapeutic drug determination

1 reference

12 December 2020

Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.

1 reference

12 December 2020

Lignocaine and indocyanine green kinetics in patients following myocardial infarction

1 reference

12 December 2020

Modelling of individual pharmacokinetics for computer-aided drug dosage

1 reference

12 December 2020

Logical approach to lignocaine therapy.

1 reference

12 December 2020

Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring.

1 reference

12 December 2020

A comparison of methods of lidocaine administration in patients.

1 reference

12 December 2020

Pharmacokinetics of antiarrhythmic drugs

1 reference

12 December 2020

Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction.

1 reference

12 December 2020

Population pharmacokinetic parameters in patients treated with oral mexiletine

1 reference

12 December 2020

Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.

1 reference

12 December 2020

Lidocaine efficacy and toxicity assessed by a new, rapid method.

1 reference

12 December 2020

10.2165/00003088-198409040-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

30 September 2017

0 references

1 reference